Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.

@article{Li2008FeverAT,
  title={Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis.},
  author={C P Li and Yee Chao and L. T. Tai-Hua Chen and R Z Lee and W. P. Andrew Lee and Jeng-Nian Yuan and Sang-Hue Yen and S V Lee},
  journal={Scandinavian journal of gastroenterology},
  year={2008},
  volume={43 8},
  pages={992-9}
}
OBJECTIVE Post-treatment fever frequently occurs in hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE), but its incidence and clinical significance are unclear. The aim of this study was to identify the incidence and risk factors for fever after TACE in HCC patients. MATERIAL AND METHODS Forty-one consecutive HCC patients… CONTINUE READING